CSS LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$123K Buy
+500
New +$127K 0.01% 798
2024
Q3
– Sell
-500
Closed -$122K – 831
2024
Q2
$122K Buy
+500
New +$78.9K 0.01% 742
2022
Q3
– Sell
-5,000
Closed -$729K – 1047
2022
Q2
$729K Buy
+5,000
New +$709K 0.03% 487
2022
Q1
– Sell
-5,000
Closed -$848K – 1157
2021
Q4
$848K Buy
+5,000
New +$929K 0.03% 487

Other funds holding ALNY

CSS LLC's ALNY Position: Q3 2026 in Review

CSS LLC opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 40 shares worth $9.9K. The stake represents ﹤0.01% of the portfolio and ranks #963 among its holdings. This is a return to the name: CSS LLC previously reported a position in ALNY as recently as Q3 2025.

CSS LLC first reported a position in ALNY in Q3 2022 and has held it in 5 quarters since. The position peaked at $2.06M in Q3 2024. 722 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • CSS LLC held 40 shares of Alnylam Pharmaceuticals worth $9.9K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new CSS LLC position in Q3 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of CSS LLC's portfolio in Q3 2026, its #963 holding.
  • CSS LLC first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • CSS LLC's Alnylam Pharmaceuticals position peaked at $2.06M in Q3 2024.
  • 722 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on CSS LLC's 13F filing for Q3 2026, filed 16 Nov 2026.